141st APHA Annual Meeting and Exposition

Home Events & Meetings Annual Meeting Schedule & Program

Recorded Annual Meeting Presentations (RAMP) are now available for purchase.
Only $90 for presenters, $140 for registered attendees and $200 for non-attendees.

Online Program

4239.0
Drug review and approval in US and Europe, adverse effects, hospital use, prior approval

Tuesday, November 5, 2013: 12:30 p.m. - 2:00 p.m.
Oral
This session will review some emerging issues at intersection of public health and pharmacy. The issues range from the concerns of medications in the environment to the diversion of drugs of abuse. Attendees will learn how other public health practitioners and other health professionals are studying these issues and how their learned lessons can be applied to other settings
Session Objectives: Describe two issues related to the use of drugs and their impact of the costs associated with hospital utilization Discuss the concern of medications in the environment and how public health officials and the pharmaceutical industry need to change in response Compare the drug approval processes between the US and European Union and discuss a concern related to the drug approval process in the US
Moderator:
Andrew Peterson, PharmD, PhD
Organizer:
Andrew Peterson, PharmD, PhD

12:30pm
Identifying adverse drug events after discharge from a community hospital   
Dennis Tsilimingras, MD, MPH
     
12:45pm
Association of prescribed opioid analgesics, benzodiazepines, and antidepressants with duration of hospitalization: A national cohort study   
Barbara Turner, MD, MSED, MACP, Yuanyuan Liang, PhD, Christopher Louden, MS, Benjamin Ehler, MS and KoKo Aung, MD, MPH
1:00pm
Does prior authorization of buprenorphine/naloxone save money or reduce diversion?   
Robin Clark, PhD
     
1:15pm
What do we know about the mechanism of action of drugs in the different drug classes? Assessment of the pharmaceuticals approved by the FDA between 1980 and 2012   
Lita Araujo, Soeun Kwon, Michael Montagne and Enrique Seoane-Vazquez
     
  
1:30pm
A comparison of new drugs approved by the EMA and the FDA in 1999-2011   
Saad Alqahtani, B.Sc.Pharm, Nasser Alshehri, PharmD, Ebtissam Badawoud, B.Sc.Pharm, Enrique Seoane-Vazquez, PhD and Rosa Rodriguez-Monguio, PhD, MS
     

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Medical Care
Endorsed by: Injury Control and Emergency Health Services

See more of: Medical Care